BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4399850)

  • 1. Antifolate resistance and the genetic control of dihydrofolate reductase activity.
    Hutchison DJ
    Ann N Y Acad Sci; 1971 Nov; 186():172-81. PubMed ID: 4399850
    [No Abstract]   [Full Text] [Related]  

  • 2. Substrate and inhibitor complexes of dihydrofolate reductase from amethopterin-resistant L1210 cells.
    Neef VG; Huennekens FM
    Arch Biochem Biophys; 1975 Dec; 171(2):435-43. PubMed ID: 959
    [No Abstract]   [Full Text] [Related]  

  • 3. Dihydrofolate reductase activity and loss of resistance in an antifolate-resistant subline of leukemia L1210 after discontinuation of treatment.
    Schrecker AW; Mead JA; Greenberg NH; Goldin A
    Chem Biol Interact; 1970 Oct; 2(3):229-34. PubMed ID: 5289825
    [No Abstract]   [Full Text] [Related]  

  • 4. Lack of intracellular conversion of dihydrohomofolate to tetrahydrohomofolate in leukemia cells with high levels of dihydrofolate reductase.
    Nahas A; Friedkin M
    Mol Pharmacol; 1972 May; 8(3):353-61. PubMed ID: 5040933
    [No Abstract]   [Full Text] [Related]  

  • 5. Dual consequence of mutation in the dihydrofolate reductase gene of Diplococcus pneumoniae.
    Sirotnak FM
    Biochem Biophys Res Commun; 1969 Aug; 36(4):603-7. PubMed ID: 4390189
    [No Abstract]   [Full Text] [Related]  

  • 6. A mechanism of resistance to methotrexate. NADPH but not NADH stimulation of methotrexate binding to dihydrofolate reductase.
    Kamen BA; Whyte-Bauer W; Bertino JR
    Biochem Pharmacol; 1983 Jun; 32(12):1837-41. PubMed ID: 6882460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited effectiveness of in vitro high-dose methotrexate and leucovorin to overcome resistance in L1210 leukemia cells with elevations of dihydrofolate reductase.
    Bruckner H; Rubinoff M; Waxman S
    Eur J Cancer (1965); 1980 Aug; 16(8):1057-63. PubMed ID: 6969180
    [No Abstract]   [Full Text] [Related]  

  • 8. Dihydrofolate reductases: structural and mechanistic aspects.
    Huennekens FM; Dunlap RB; Freisheim JH; Gundersen LE; Harding NG; Levison SA; Mell GP
    Ann N Y Acad Sci; 1971 Nov; 186():85-99. PubMed ID: 4400072
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence for a genetic alteration of dihydrofolate reductase associated with amethopterin resistance in Diplococcus pneumoniae.
    Sirotnak FM; Donati GJ; Hutchison DJ
    Biochem Biophys Res Commun; 1964; 14():292-5. PubMed ID: 4378682
    [No Abstract]   [Full Text] [Related]  

  • 10. Levels of dihydrofolate reductase and thymidylate synthetase in strains of Streptococcus faecium resistant to substituted pyrimidines, triazines and MTX.
    Smith CC; Freisheim JH
    Ann N Y Acad Sci; 1971 Nov; 186():182-4. PubMed ID: 5002296
    [No Abstract]   [Full Text] [Related]  

  • 11. Improved purification of tetrahydrofolate dehydrogenase from L1210 leukemia by affinity chromatography.
    Chello PL; Cashmore AR; Jacobs SA; Bertino JR
    Biochim Biophys Acta; 1972 Apr; 268(1):30-4. PubMed ID: 5018279
    [No Abstract]   [Full Text] [Related]  

  • 12. Antifolate polyglutamylation and competitive drug displacement at dihydrofolate reductase as important elements in leucovorin rescue in L1210 cells.
    Matherly LH; Barlowe CK; Goldman ID
    Cancer Res; 1986 Feb; 46(2):588-93. PubMed ID: 2416428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of thymidylate synthetase and dihydrofolate reductase enzymes in vitro and in vivo.
    Kawai M; Hillcoat BL
    Cancer Res; 1974 Jul; 34(7):1619-26. PubMed ID: 4833915
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunologic heterogeneity of dihydrofolate reductase from methotrexate sensitive and resistant L1210 leukemia cells.
    Iqbal MP; Rothenberg SP; Larosa C
    Proc Soc Exp Biol Med; 1985 Oct; 180(1):98-102. PubMed ID: 2412235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased dihydrofolate reductase synthess in Diplococcus pneumoniae following translatable alteration of the structural gene. I. Genotype derivation and recombinational analyses.
    Sirotnak FM; Hachtel SL
    Genetics; 1969 Feb; 61(2):293-312. PubMed ID: 4390084
    [No Abstract]   [Full Text] [Related]  

  • 16. Differentiating properties of the dihydrofolate reductases of amethopterin-resistant Streptococcus faecalis/Ak and the sensitive parent strain.
    Albrecht AM; Palmer JL; Hutchison DJ
    J Biol Chem; 1966 Mar; 241(5):1043-8. PubMed ID: 4379861
    [No Abstract]   [Full Text] [Related]  

  • 17. The intracellular concentration dependence of antifolate inhibition of DNA synthesis in L1210 leukemia cells.
    Sirotnak FM; Donsbach RC
    Cancer Res; 1974 Dec; 34(12):332-40. PubMed ID: 4429954
    [No Abstract]   [Full Text] [Related]  

  • 18. The amino acid sequence of dihydrofolate reductase from L1210 cells.
    Stone D; Phillips AW
    FEBS Lett; 1977 Feb; 74(1):85-8. PubMed ID: 402293
    [No Abstract]   [Full Text] [Related]  

  • 19. A new fluorescent dihydrofolate reductase probe for studies of methotrexate resistance.
    Rosowsky A; Wright JE; Shapiro H; Beardsley P; Lazarus H
    J Biol Chem; 1982 Dec; 257(23):14162-7. PubMed ID: 7142200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dihydrofolate reductase activity of leukemia L1210 during development of methotrexate resistance.
    Schrecker AW; Mead JA; Greenberg NH; Goldin A
    Biochem Pharmacol; 1971 Mar; 20(3):716-8. PubMed ID: 5150168
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.